Tianjin Ringpu Bio Tech
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company provides anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, i… Read more
Tianjin Ringpu Bio Tech (300119) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.020x
Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has a cash flow conversion efficiency ratio of 0.020x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥105.02 Million) by net assets (CN¥5.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tianjin Ringpu Bio Tech - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Tianjin Ringpu Bio Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tianjin Ringpu Bio Tech Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beingmate Baby & Child Food Co Ltd
SHE:002570
|
0.012x |
|
Jiangsu Yueda Investment Co Ltd
SHG:600805
|
0.002x |
|
Sinopec Shanghai Petrochemical Company Limited
PINK:SPTJF
|
0.404x |
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS
|
0.053x |
|
Embla Medical hf
CO:EMBLA
|
0.060x |
|
Long Young Electronic (Kunshan) Co. Ltd. A
SHE:301389
|
N/A |
|
Jiangyin Haida Rubber and Plastic Co Ltd Class A
SHE:300320
|
0.017x |
|
Diös Fastigheter AB (publ)
F:D1F
|
0.026x |
Annual Cash Flow Conversion Efficiency for Tianjin Ringpu Bio Tech (2007–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Ringpu Bio Tech from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.01 Billion | CN¥735.55 Million | 0.147x | +86.64% |
| 2023-12-31 | CN¥4.80 Billion | CN¥378.20 Million | 0.079x | -9.04% |
| 2022-12-31 | CN¥4.50 Billion | CN¥389.49 Million | 0.087x | -2.22% |
| 2021-12-31 | CN¥4.32 Billion | CN¥382.63 Million | 0.088x | -37.64% |
| 2020-12-31 | CN¥2.74 Billion | CN¥388.44 Million | 0.142x | -12.80% |
| 2019-12-31 | CN¥2.36 Billion | CN¥383.61 Million | 0.163x | +109.80% |
| 2018-12-31 | CN¥2.25 Billion | CN¥174.88 Million | 0.078x | +56.93% |
| 2017-12-31 | CN¥2.18 Billion | CN¥107.57 Million | 0.049x | -49.89% |
| 2016-12-31 | CN¥2.11 Billion | CN¥207.67 Million | 0.099x | -22.55% |
| 2015-12-31 | CN¥1.77 Billion | CN¥225.27 Million | 0.127x | +71.20% |
| 2014-12-31 | CN¥1.73 Billion | CN¥128.37 Million | 0.074x | +44.29% |
| 2013-12-31 | CN¥1.72 Billion | CN¥88.68 Million | 0.052x | -9.05% |
| 2012-12-31 | CN¥1.59 Billion | CN¥89.92 Million | 0.057x | -6.07% |
| 2011-12-31 | CN¥1.50 Billion | CN¥90.29 Million | 0.060x | -23.68% |
| 2010-12-31 | CN¥1.43 Billion | CN¥112.82 Million | 0.079x | -69.09% |
| 2009-12-31 | CN¥252.48 Million | CN¥64.59 Million | 0.256x | -6.06% |
| 2008-12-31 | CN¥249.97 Million | CN¥68.07 Million | 0.272x | +93.74% |
| 2007-12-31 | CN¥136.21 Million | CN¥19.15 Million | 0.141x | -- |